Stock-based Compensation - Additional Information (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
| Stock compensation expense | $ 148,024 | $ 129,781 | $ 232,155 | $ 377,899 |
| Board of Director Member | ||||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
| Number of stock options granted | 308,039 | 86,669 | ||
| Stock option, strike price | $ 1.89 | $ 2.81 | $ 1.89 | $ 2.81 |
| Performance-based options, Granted | 45,000 | 25,000 | ||
| Performance-based options, weighted average strike price | $ 2.16 | $ 1.33 | ||
| Employee | ||||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
| Stock option, aggregate grant date fair value | $ 489,108 | $ 338,741 | $ 489,108 | $ 338,741 |
| X | ||||||||||
- Definition Performance-Based Options, Weighted Average Strike Price No definition available.
|
| X | ||||||||||
- Definition Share-based compensation arrangement by share-based payment award options grants in period grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|